TPI deficiency is a rare human condition. Patients who lack TPI cannot convert the triose dihydroxyacetone phosphate into glyceraldehyde 3-phosphate. What happens to glycolysis in TPI patients? TPI patients suffer from chronic hemolytic anemia (abnormal breakdown of red blood cells) and have variable neuromuscular dysfunctions, including muscle weakness, poor muscle tone, and atrophy. Most die of respiratory failure during childhood. Explain why TPI-deficient patients exhibit these conditions using the diagram to justify your answer. TPI is enzyme 5.

Biochemistry
6th Edition
ISBN:9781305577206
Author:Reginald H. Garrett, Charles M. Grisham
Publisher:Reginald H. Garrett, Charles M. Grisham
Chapter22: Gluconeogenesis, Glycogen Metabolism, And The Pentose Phosphate Pathway
Section: Chapter Questions
Problem 8P
icon
Related questions
Question

TPI deficiency is a rare human condition. Patients who lack TPI cannot convert the triose
dihydroxyacetone phosphate into glyceraldehyde 3-phosphate.
What happens to glycolysis in TPI patients?

TPI patients suffer from chronic hemolytic anemia (abnormal breakdown of red blood cells)
and have variable neuromuscular dysfunctions, including muscle weakness, poor muscle tone,
and atrophy. Most die of respiratory failure during childhood.
Explain why TPI-deficient patients exhibit these conditions using the diagram to justify your
answer. TPI is enzyme 5.

G6PD deficiency is one of the most common human genetic conditions, affecting about 40 million
people worldwide. Patients suffer from hemolytic anemia when exposed to certain drugs, viral or
bacterial disease, or fava beans.

HANDOUT A
Glucose-6 Phosphate
Dehydrogenase and TPI Deficiencies
OH
OH
2-O,PO-CH, OH
O
*OPO—CH,
CH,OH
OH
Mutase
OH
OH
2-0,PO-CH₂ Q
OH
2,3-Bisphosphoglycerate
Phosphatase
OH
HỌ
2,3-Bisphosphoglycerate
Bisphosphoglycerate
НО
OH
OH
CH,OH
OH
CH₂-OPO,²-
OH
ATP+
C-OPO,²-
CH₂
Glucose
ATP
HC=O
HC-OH Glyceraldehyde-3-P
H₂C-OPO,²- P
NAD
NADH
H₂O+
Glucose-6-P
ATP
Fructose-6-P◄
1,3-Bisphosphoglycerate
Fructose-1,6-BP
1 Hexokinase
ATP 3 Phosphofructokinase-1
-O
HC OH 3-Phosphoglycerate
H₂C-OPO,²
Glucose-6-Phosphate
Dehydrogenase
2 Phosphoglucoisomerase
Pyruvate
Triose
H₂C-OH
Phosphate Dihydroxyacetone-P C=O
Isomerase
Glyceraldehyde-3-P
dehydrogenase
2-Phosphoglycerate
NADP NADPH
A
4 Aldolase
Phosphoglycerate
kinase
Phosphoenolpyruvate
Phosphoglycerate
mutase
8 Enolase
6-phosphoglucolactone.
Pyruvate kinase
Non-oxidative Phase of Pentose
Phosphate Pathway
H₂C-OPO,¹
0=000
-OPO,²-
HC-OH
H₂C-OPO,¹
요。
HC-OPO,
H₂C-OH
c=o
CH₂
H₂O
H
6-Phosphoglucolactonase
6-phosphogluconate
6-Phosphogluconate Dehydrogenase
NADP+
NADPH
CO₂
Ribulose-5-Phosphate
The diagram above shows two shunts from glycolysis. The first, the oxidative pentose phosphate
shunt (or the hexose monophosphate pathway, HMP), generates five carbon sugars (pentoses) and
NADPH. The pentoses are used in nucleotide synthesis reactions, and the NADPH is used is in
fatty acid synthesis and in reduction reactions. The reduction reactions are important in red blood
cells to help reduce oxidative stresses on the cell membranes.
The second pathway, the Rapoport-Luebering glycolytic shunt, produces 2,3-bisphosphoglycerate,
which helps to displace oxygen in red blood cells; this aids in oxygen delivery to the tissues.
At least two human conditions affect glycolytic pathways: glucose 6-P dehydrogenase (G6PD)
deficiency and triose phosphate isomerase (TPI) deficiency. G6PD deficiency is an X-linked disease,
while the TPI gene is found on chromosome 12.
Transcribed Image Text:HANDOUT A Glucose-6 Phosphate Dehydrogenase and TPI Deficiencies OH OH 2-O,PO-CH, OH O *OPO—CH, CH,OH OH Mutase OH OH 2-0,PO-CH₂ Q OH 2,3-Bisphosphoglycerate Phosphatase OH HỌ 2,3-Bisphosphoglycerate Bisphosphoglycerate НО OH OH CH,OH OH CH₂-OPO,²- OH ATP+ C-OPO,²- CH₂ Glucose ATP HC=O HC-OH Glyceraldehyde-3-P H₂C-OPO,²- P NAD NADH H₂O+ Glucose-6-P ATP Fructose-6-P◄ 1,3-Bisphosphoglycerate Fructose-1,6-BP 1 Hexokinase ATP 3 Phosphofructokinase-1 -O HC OH 3-Phosphoglycerate H₂C-OPO,² Glucose-6-Phosphate Dehydrogenase 2 Phosphoglucoisomerase Pyruvate Triose H₂C-OH Phosphate Dihydroxyacetone-P C=O Isomerase Glyceraldehyde-3-P dehydrogenase 2-Phosphoglycerate NADP NADPH A 4 Aldolase Phosphoglycerate kinase Phosphoenolpyruvate Phosphoglycerate mutase 8 Enolase 6-phosphoglucolactone. Pyruvate kinase Non-oxidative Phase of Pentose Phosphate Pathway H₂C-OPO,¹ 0=000 -OPO,²- HC-OH H₂C-OPO,¹ 요。 HC-OPO, H₂C-OH c=o CH₂ H₂O H 6-Phosphoglucolactonase 6-phosphogluconate 6-Phosphogluconate Dehydrogenase NADP+ NADPH CO₂ Ribulose-5-Phosphate The diagram above shows two shunts from glycolysis. The first, the oxidative pentose phosphate shunt (or the hexose monophosphate pathway, HMP), generates five carbon sugars (pentoses) and NADPH. The pentoses are used in nucleotide synthesis reactions, and the NADPH is used is in fatty acid synthesis and in reduction reactions. The reduction reactions are important in red blood cells to help reduce oxidative stresses on the cell membranes. The second pathway, the Rapoport-Luebering glycolytic shunt, produces 2,3-bisphosphoglycerate, which helps to displace oxygen in red blood cells; this aids in oxygen delivery to the tissues. At least two human conditions affect glycolytic pathways: glucose 6-P dehydrogenase (G6PD) deficiency and triose phosphate isomerase (TPI) deficiency. G6PD deficiency is an X-linked disease, while the TPI gene is found on chromosome 12.
Expert Solution
trending now

Trending now

This is a popular solution!

steps

Step by step

Solved in 3 steps

Blurred answer
Similar questions
  • SEE MORE QUESTIONS
Recommended textbooks for you
Biochemistry
Biochemistry
Biochemistry
ISBN:
9781305577206
Author:
Reginald H. Garrett, Charles M. Grisham
Publisher:
Cengage Learning
Anatomy & Physiology
Anatomy & Physiology
Biology
ISBN:
9781938168130
Author:
Kelly A. Young, James A. Wise, Peter DeSaix, Dean H. Kruse, Brandon Poe, Eddie Johnson, Jody E. Johnson, Oksana Korol, J. Gordon Betts, Mark Womble
Publisher:
OpenStax College